25 June 2025
Oxford Instruments plc
(the “Company”)
Commencement of Share Buyback
Further to the announcement of 10 May 2025, Oxford Instruments plc (the “Company”), a leading provider of high technology products and systems for industry and research, announces that from today it will commence a programme to purchase up to £50 million
of the Company's ordinary shares of
5 pence
each (the "Ordinary Shares") (the "Programme") by no later than 24 June 2026.
The purpose
of the Programme is to reduce the Company's share capital and accordingly the Company intends to cancel the Ordinary Shares purchased under the Programme however the Company may transfer some shares to Treasury to be used in relation to the Company’s employee share option plans.
Any purchases will be conducted in compliance with the relevant conditions for trading, restrictions regarding time and volume, disclosure and reporting obligations, and price conditions. The Company confirms that it currently has no unpublished Inside Information.
The Programme will be conducted by the Company in accordance with and under the terms of the general authority granted by the Company's shareholders at the Company's Annual General Meeting on
25 July 2024, which authority will expire at the end of the next Annual General Meeting of the Company in 2025 or, if earlier, at the close of business on
30 September 2025 ("2024 Authority").
Purchases effected following the expiry of the 2024 Authority will be conditional on a similar shareholder authority being granted at the Company's annual general meeting to be held on 28 July 2025.
The Company has appointed its broker Numis Securities Limited ("Deutsche Numis") to manage the Programme and has issued an irrevocable instruction to Deutsche Numis to continue to manage the Programme, within pre-set parameters, during any closed period.
The Programme will be carried out on the London Stock Exchange and other trading venues
1
and executed within the parameters of the Market Abuse Regulation 596/2014/EU and the Commission Delegated Regulation 2016/1052/EU (as each forms part of domestic law under the European Union (Withdrawal) Act 2018, including where relevant pursuant to the Market Abuse (Amendment) (EU Exit) Regulations 2019) and Chapter 9 of the
UK
Listing Rules of the Financial Conduct Authority.
The aggregate maximum consideration payable by the Company in respect of the purchase of shares under the Programme is £50 million. The maximum number of shares that may be purchased under the Programme is 5,791,927 (being the number of shares able to be purchased under the 2024 Authority).
1
Turquoise, Chi-X Europe and BATS Trading Europe.
Enquiries:
Oxford Instruments plc
Richard Tyson, Chief Executive Officer
Paul Fry, Chief Financial Officer
Stephen Lamacraft, Head of Investor Relations
Stephen.lamacraft@oxinst.com
MHP Group
Katie Hunt/Tim Rowntree/
07710 117517
Veronica Farah
oxfordinstruments@mhpgroup.com
Notes to Editors
About Oxford Instruments plc
Oxford Instruments provides academic and commercial organisations worldwide with market-leading scientific technology and expertise across its key market segments: materials analysis, semiconductors, and healthcare & life science. Innovation is the driving force behind Oxford Instruments' growth and success, supporting its core purpose to accelerate the breakthroughs that create a brighter future for our world. The vigorous search for new ways to make our world greener, healthier and more productive is driving unprecedented levels of R&D investment in new materials and techniques to support productivity and decarbonisation worldwide, creating a significant opportunity for Oxford Instruments to grow. Oxford Instruments holds a unique position to anticipate global drivers and connect academic researchers with commercial applications engineers, acting as a catalyst that powers real world progress. Founded in 1959 as the first technology business to be spun out from Oxford University, Oxford Instruments is now a global, FTSE250 company listed on the London Stock Exchange (OXIG). For more information, visit www.oxinst.com
